20 LATEST RESOURCES (43 INDEXED)
×
Impact of Reboxetine Plus Oxybutynin Treatment for Obstructive Sleep Apnea on Cardiovascular Autonomic Modulation · February 2023
Articles
Scientific Reports
×
Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial · September 2021
Articles
Chest
×
The Noradrenergic Agent Reboxetine Plus the Antimuscarinic Hyoscine Butylbromide Reduces Sleep Apnoea Severity: A Double-Blind, Placebo-Controlled, Randomised Crossover Trial · September 2021
Abstracts
Journal of Physiology
×
Adjunctive Reboxetine for Schizophrenia: Meta-Analysis of Randomized Double-Blind, Placebo-Controlled Trials · June 2019
Abstracts
Pharmacopsychiatry
×
Reboxetine in Therapy-Resistant Enuresis: A Randomized Placebo-Controlled Study · July 2016
Abstracts
Journal of Pediatric Urology
×
Reboxetine Adjuvant Therapy in Patients with Schizophrenia Showing a Suboptimal Response to Clozapine: A 12-Week, Open-Label, Pilot Study · October 2014
Abstracts
Journal of Clinical Psychopharmacology
×
The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder · September 2014
Articles (Manuscripts-Versions)
University of California>Clinical EEG and Neuroscience
×
Double-Blind, Placebo-Controlled Study of the Efficacy of Reboxetine and Citalopram as Adjuncts to Atypical Antipsychotics for Negative Symptoms of Schizophrenia · June 2014
Abstracts
Journal of Clinical Psychiatry
×
Allowing for Non-Adherence to Treatment in a Randomized Controlled Trial of Two Antidepressants (Citalopram versus Reboxetine): An Example from the GENPOD Trial · March 2014
Articles
Psychological Medicine
×
Effectiveness of Reboxetine in Treatment of Outpatient Children and Adolescents with Attention Deficit-Hyperactivity Disorder with Comorbid Anxiety Disorders · October 2013
Articles
NCBI>Iranian Journal of Psychiatry
×
The Effect of Reboxetine Co-Administration with Olanzapine on Metabolic and Endocrine Profile in Schizophrenia Patients · July 2013
Abstracts
Psychopharmacology
×
Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients with Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial · March 2013
Abstracts
Clinical Neuropharmacology
×
Reducing Antipsychotic-Induced Weight Gain in Schizophrenia: A Double-Blind Placebo-Controlled Study of Reboxetine-Betahistine Combination · December 2012
Abstracts
Psychopharmacology
×
Effects of Reboxetine and Citalopram on Appraisal of Infant Facial Expressions and Attentional Biases · September 2011
Articles
Journal of Psychopharmacology
×
Neuroanatomical Targets of Reboxetine and Bupropion as Revealed by Pharmacological Magnetic Resonance Imaging · May 2011
Abstracts
Psychopharmacology
×
Efficacy of Reboxetine in Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled Clinical Trial · February 2011
Abstracts
Human Psychopharmacology: Clinical and Experimental
×
The Effect of a 4-Week Treatment with Reboxetine on Metabolic Parameters of Depressed Inpatients · October 2010
Abstracts
European Archives of Psychiatry and Clinical Neuroscience
×
Reboxetine for ADHD in Children Non-Responders or with Poor Tolerance to Methylphenidate: A Prospective Long-Term Open-Label Study · May 2010
Abstracts
ADHD Attention Deficit and Hyperactivity Disorders